Skip to content
Media UK

The Zimbabwean Government Rejects ‘Unbalanced’ American Health Aid Deal Due to Data Fears

Health aid illustration
The offered American funding was aimed at programmes for HIV/Aids treatment and prevention, tuberculosis, and malaria.

The nation of Zimbabwe has rejected a major US healthcare agreement worth 367 million US dollars (£272m) spanning five years because of Washington's request for sensitive information.

This rejection was revealed after a government memo from December was leaked, indicating that President Emmerson Mnangagwa deemed the arrangement was "skewed".

An official spokesperson has since stated that the United States was demanding access to health data for research and commercial gain while was not willing to guarantee the resulting advantages from any future medical innovations.

"We must now begin the challenging and unfortunate task of scaling back our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy said the United States had furnished more than $1.9bn in health funding to Zimbabwe during the past two decades.

A medical body in Zimbabwe has called for more talks to secure a agreement agreeable to both sides so the nation's critical HIV treatment initiative can be sustained.

Wider Implications

This development follows a comparable situation in Kenya, where a high court blocked a similar deal with the US following concerns were raised about the safety of citizens' medical information.

Since returning to office last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).

The agency had overseen assistance for the American government, but Trump stated its spending was "inefficient" and his government was pursuing government-to-government deals to boost openness and accountability.

As per statements, 16 African countries have so far signed these new agreements, constituting more than $18.3bn of fresh investment.

Specifics of the Rejected Deal

The money for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"It is our view this cooperation could have provided significant benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving antiretroviral therapy via American-funded programmes," Tremont added.

However, government spokesperson Nick Mangwana argued the arrangement was "asymmetrical".

"The proposal required Zimbabwe to share its biological resources and data for a long time, without any corresponding promise of benefiting from any medical innovations – like new medicines or tests – that might result from that provided information," he stated.

"In essence, our country would provide the raw materials for scientific discovery with no assurance that the final treatments would be accessible to our citizens should a future pandemic emerge."

Sovereignty and Global Health

He also pointed out that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were disrupting systems previously established via the global health agency.

Mangwana gave as an example its Pandemic Benefit-Sharing framework created to manage potential global health emergencies.

"This system is intended to ensure that when a nation provides its data, the resulting advantages – such as medicines and cures – are shared equitably, not commercialised solely by those with the funds to create them."

Zimbabwe's reservations over the US deal "should not be misconstrued as hostility towards the US," he added.

"We welcome continued discussions with our American counterparts on how subsequent collaboration might be arranged in a way that honours the sovereignty and dignity of both nations."

Health Experts Reaction

Medical experts stated it acknowledged the government's concerns, but recommended that negotiations must proceed given that a large portion of the nation's HIV programmes were funded by international support.

"Where technical issues exist, such as those involving data governance or agreement terms, these can often be resolved through detailed discussion and negotiated safeguards," the group said.

The situation underscores the complex challenges between receiving vital foreign assistance and protecting national sovereignty in an ever more data-driven world.

Written by

Katherine Chen

Award-winning journalist with over 15 years of experience covering media and technology, currently based in London.

Media UK

Type to search articles.